Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu

Clinical Pharmacology Publications - 2009

2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995

  • Vella-Brincat J, McKean A. Audit of antipsychotic polypharmacy in Christchurch. (Letter) Australas Psychiatry 2009; 17(4), 336-7 [Letter]
  • Doogue M, Martin J, Miners J, Somogyi A. Prescribing in liver disease (Letter). Aust Prescr 2009; 32(5), 120 [Abstract]
  • Stamp LK, O'Donnell JL, Chapman PT, Zhang M, Frampton C, James J, Barclay ML. Determinants of red blood cell methotrexate polyglutamate concentrations in patients with rheumatoid arthritis on long-term MTX. Arthritis Rheumatol 2009; 60(8), 2248-56 [Abstract]
  • Stamp LK, O’Donnell JL, Chapman PT, Barclay ML, Kennedy MA. Lack of association between HLA-G 14 bp insertion/deletion polymorphism and response to long-term therapy with methotrexate response in rheumatoid arthritis. Ann Rheum Dis 2009; 68(1), 154-5 [Abstract]
  • Doogue MP, Begg EJ, Moore MP, Lunt H, Pemberton CJ, Zhang M. Metformin increases plasma ghrelin in Type 2 Diabetes. Br J Clin Pharmacol 2009; 68(6), 875-82 [Abstract]
  • Sung, EYY, Moore, MP, Lunt, H, Doogue, MP, Zhang, M, Begg, EJ. Do thiazide diuretics alter the pharmacokinetics of metformin in patients with type 2 diabetes already established on metformin? (Letter) Br J Clin Pharmacol 2009; 67(1), 130-1 [Abstract]
  • Petermann I, Triggs CM, Huebner C, Han DY, Gearry RB, Barclay ML. Mushroom intolerance: a novel diet-gene interaction in Crohn’s disease. Br J Nutr 2009; 102(4), 506-8 [Abstract]
  • Huebner C, Ferguson LR, Han DY, Philpott M, Barclay ML, et al. Nucleotide-binding oligomerization domain containing 1 (NOD1) haplotypes and single nucleotide polymorphisms modify susceptibility to IBDs in NZ Caucasian population: a case-control study. BMC Res Notes 2009; 2(52), 1-9 [Abstract]
  • Whiting MJ, Doogue MD. Advances in biochemical screening for phaeochromocytoma using biogenic amines. Clin Biochem Rev 2009; 30(1), 3 [Abstract]
  • McLean AG, Petersons CJ, Hooper AJ, Doogue MD, et al. Extreme diabetic lipaemia associated with a novel lipoprotein lipase gene mutation. Clin Chim Acta 2009; 406(1), 167-9 [Abstract]
  • Polasek TM, Polak S, Doogue MP, et al. Assessment of inter-individual variability in predicted phenytoin clearance. Eur J Clin Pharmacol 2009; 65(12), 1203-10 [Abstract]
  • Ferguson LR, Han DY, Huebner C, Petermann I, Barclay ML. Tumor necrosis factor receptor superfamily, member 1B haplotypes increase or decrease the risk of IBD in a NZ Caucasian population. Gastroenterol Res Pract 2009; 2009, 1-9 [Abstract]
  • Petermann I, Huebner C, Browning BL, Gearry RB, Barclay ML. Interactions among genes influencing bacterial recognition increase IBD risk in a population-based NZ cohort. Hum Immunol 2009; 70, 440-6 [Abstract]
  • Huebner C, Browning BL, Petermann I, Han DY, Barclay M, et al. Genetic analysis of MDRI and IBD reveals protective effect of heterozygous variants for ulcerative colitis. Inflamm Bowel Dis 2009; 15, 1784-93 [Abstract]
  • Parasca A, Doogue MP, Woodman RJ, Angoni AA. Hypoalbuminaemia and impaired renal function are associated with increased anticholinergic drug prescribing. Int J Clin Pract 2009; 63(7), 1110-4 [Abstract]
  • Doogue MP, Martin J. Guidelines or external regulation? Intern Med J 2009; 39(12), 789-91 [Abstract]
  • Chin PKL, Beckett LEL, Gunningham S, Edwards AL, Robinson BA. Audit of anticoagulant thrombopropylaxis in hospitalized oncology patients. Intern Med J 2009; 39(12), 819-25 [Abstract]
  • Begg EJ, Vella-Brincat JWA, Robertshawe B, McMurtrie MJ, Kirkpatrick CMJ, Darlow B. Eight years’ experience of an extended-interval dosing protocol for gentamicin in neonates. J Antimicrob Chemother 2009; 63(5), 1043-9 [Abstract]
  • Zhang M, Moore GA, Barclay ML, Begg, EJ. Determination of perhexiline and its metabolite hydroxyperhexiline in human plasma by liquid chromatography/tandem mass spectrometry. J Chromatogr B 2009; 877(27), 3025-30 [Abstract]
  • Martin JH, Beer C, Morris RG, Doogue MP. Doctors and the pharmaceutical industry: time for a national policy? Med J Aust 2009; 191(3), 189-90 [Abstract]
  • Doogue MP, Knights KM. What changes are needed to the current direction and interpretation of clinical cancer research to meet the needs of the 21st century? Med J Aust 2009; 191(3), 190 [Abstract]
  • Chin P, Lunt H. Insights into future directions for diabetes management and prevention. NZ Med J 2009; 122(1288), 6-8 [Abstract]
  • Sharp CF, Gardiner SJ, Jensen BP, Roberts RL, Troughton RW, Lainchbury JG, Begg EJ. CYP2D6 genotype and its relationship with metoprolol dose, concentrations and effect in patients with systolic heart failure. Pharmacogenomics J 2009; 9(3), 175-84 [Abstract]
  • Schouten BJ, Doogue MD, Soule SG, Hunt PJ. Iron polymaltose-induced FGF23 elevation complicated by hypophosphataemic osteomalacia. Ann Clin Biochem 2009; 46(2), 167-9 [Abstract]
  • MacLeod R, Vella-Brincat J, MacLeod ADS. The Palliative care Handbook incorporating the Nurse Maude Palliative care formulary guidelines for clinical management and symptom control. (Book) 2009, 4th edition